Twin Registries: The Neglected Population Resource
Sir, Psychiatry has undergone a major paradigm shift, from concentrating on what is in the mind to what is in the brain. Major strides in finding the neurobiological basis of mental illnesses have been possible due to the fundamental building blocks of genetic epidemiological studies including family studies, twin studies, linkage and chromosomal analysis, which have shown an elusive promise to bring out psychiatry from the realms of scientific obscurity to the reigns of modernity.
Twinning has been known to humankind since its inception. Twins have been ubiquitous in all regional mythological tales often represented as the significant another aspect of the self. Twins constitute around 1.8% of the adult population. [1] Galton was the first person to recognize their value for studying the heritability of traits to tease out the relative effects of nature versus nurture. [2] In the field of mental health, such studies have been instrumental in the search for allelic variants responsible for Alzheimer's, depression, schizophrenia, autism, attention deficit hyperactivity disorder, etc., and also in establishing the genetics of traits such as neuroticism, intelligence and aggression. This has been made possible by a number of twin registries which have provided the required population cohorts for research.
Twin registry is a collection of data pertaining to twins often maintained at a national level or at a research center. The developed world has a number of twin registries, especially in USA, Australia, UK, Sweden and Finland, with many being involved in mental health research. However, there is a dearth of representation from the lower and middle-income countries, with only a few registries in Nigeria, Guinea-Bissau, Mongolia, and Cuba. Sri Lankan and Thai twin registries are the only representations from the WHO-SEAR countries. [3] India is conspicuous by its glaring absence from this scene despite the huge population resource of the country. Although India has a lower twinning rate (7.2/1000), the sheer number of twin births (2685 in 1996-2006) provides an untapped potential for genetic epidemiological studies. [4] So far there is only one such registry in India -The Chennai twin registry, which was established in July 2008. No studies have yet been published from this, though proposals have been accepted. Twin studies in mental health from India are scarce with only three published case reports of mental disorders in identical twins. [5] As Tim Spector, founder of the UK twin registry rightly sums up "Twin studies are the only real way of doing natural experiments in humans." The absence of such studies from India shows a lack of impetus for genetic research. Population is our abundant natural resource and initiatives for its adequate utilization in research need to be undertaken. The government can aid this by utilizing the existing infrastructure of primary health care for registration of twin births and by providing research grants for conducting such studies. Tertiary institutes and big universities need to take the first steps toward this much needed endeavor.
Sir, Some of the major changes in the Diagnostic and Statistical Manual of Mental Disorders, Fifth
Edition are the relocation of obsessive-compulsive disorder (OCD) and acknowledging a delusional specifier. This should be borne in mind while working the differential for OCD/psychosis interface which might also entail -obsessive-compulsive symptoms (OCS) as a psychotic prodroma, schizotypal PD with superimposed OCD, Asperger's syndrome, "schizo-obsessive" disorder, and atypical antipsychotic (AAP)-induced OCS.
AAPs are a common augmentative strategy in treatment-resistant OCD. Moreover, some have contended that dopamine blockade is critical to facilitate 5-hydroxytryptamine (5HT) transmission in the cortico-striato-pallido-thalamo-cortical neurocircuitry in OCD. Indicators to use this tactic might include tics, schizotypal personality disorder, autism spectrum disorder, poor insight, and mood instability. Of the AAPs, best available evidence is for risperidone as shown in a meta-analysis by Dold et al. [1] and also aripiprazole as demonstrated by Ducasse et al. [2] in a meta-regression analysis. This would translate clinically into a lower threshold to employ AAPs in the pharmacotherapy of OCD earlier than later.
Paradoxically, APPs have been notoriously reported to induce de novo or exacerbate preexisting OCD in schizophrenia. This seems to be related chiefly to the primary diagnosis. It has also been reported in bipolar mood disorders, intellectual disability, delusional disorder, and psychotic depression. Lim et al. [3] have found an incidence of 12% of AAPs-induced OCS in a cohort of schizophrenia and schizo-affective disorder (n = 209).
Since 5HT dysregulation is central to OCD neurobiology, it seems that AAPs by virtue of 5HT2A antagonism might mechanistically induce these OCS as demonstrated by Zink. [4] Agents with higher 5HT2A affinity seem to have a stronger potential to induce OCD notably clozapine. Lin et al. [5] have found that patients developing clozapine-induced OCS had higher concentrations of clozapine and norclozapine. Kwon et al. [6] have demonstrated the association between SLC1A1 gene and AAPs-induced OCS in schizophrenia.
Poyurovsky et al. [7] have proposed clinical criteria to diagnose AAPs-induced OCS. These include male preponderance, preexisting OCS in schizophrenia, compulsions, during the 1 st week of treatment, and typically with higher doses.
Treatment typically entails dose reduction or entirely discontinuation of culprit AAP, introduction of selective serotonin reuptake inhibitors (SSRIs), or both. Aripiprazole and amisulpride by virtue of unique secondary pharmacodynamic properties remain viable options.
To pull it together, the use of APP, especially risperidone or aripiprazole, ab initio, is highly indicated in cases of bona fide OCD, earlier rather than later and more so if coupled with clinical correlates highlighted above (e.g., tic-related OCD). On the other hand, if the primary diagnosis is schizophrenia and patients phenomenologically endorse OCS, which
